Navigation Links
Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations

CHAPEL HILL, N.C., Jan. 23, 2012 /PRNewswire/ -- As the influence of Managed Care continues to grow, so too do the activities that biopharma companies carry out as part of interacting with the managed care sector. Consequently, pharmaceutical and medical device leaders have placed an increased importance on these activities, as the strength of these organizations has become closely intertwined with marketplace success.

On average, the Best Practices, LLC benchmark class drastically increased investment levels to $3 million per FTE in 2010 compared to one-half million in 2003. To meet the needs of Managed Care leaders trying to defend their resource and investment levels, Best Practices, LLC conducted a comprehensive research study to identify the industry standards for staffing data (FTE), outsourcing, budget and efficiency metrics.

In addition, relative to 2003, Managed Care groups increased the percentage of budget allocated for payor pricing activity by 13% in 2010, according to "Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," a new primary research study conducted by Best Practices, LLC.

Download a complimentary white paper at http:/ that includes selected best practices drawn from extensive primary research with 12 participants, ranging from senior leaders to managers of managed markets, from 10 leading bio-pharma and medical device companies.

Study topics include:

The full report contains over 110 benchmark metrics and critical best practices, delivering insights into the most effective Managed Care operations, tactics and activities to provide a recent look at staffing and resourcing levels in Managed Care.

Specifically, this primary research identifies the resource levels, structure and revenue of U.S. Managed Care groups for major pharmaceutical and biotechnology companies. This benchmark study provides managed care leaders with important benchmarks on the optimal size of U.S. Managed Care groups linked to activities performed to allow managed care leaders to assess their efficiency level relative to peers.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/30/2015)... -- --> --> According ... Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application (Conservative ... - Global Forecast to 2020", published by MarketsandMarkets, is expected ... of 5.2% during the forecast period from 2015 to 2020. ... Figures spread through 167 P ages and in-depth TOC ...
(Date:11/30/2015)... and ST. LOUIS , Nov. ... (NASDAQ: ESRX ) today announced an early renewal ... which began in 1999, will now extend through at ... --> After evaluating pharmacy benefit manager capabilities during ... Express Scripts continues to offer the best health plan ...
(Date:11/30/2015)... , Nov. 30, 2015 Booth #4303 – ... VAR ) will exhibit a broader array of products in ... Radiological Society of North America in ... at the meeting will feature X-ray components "At the Heart ... a line of products from Varian,s Claymount brand, and computer-aided ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class ... could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major ... showed that small molecule analogs that target the functions of SecA, a central ...
(Date:11/30/2015)... ... , ... Using a combination of two blood sugar tests rather than a ... a new study by researchers at the School of Public Health at Georgia State ... of Blood Glucose Tests ,” published in Frontiers in Public Health, the researchers noted ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology ... UPMC and KingMed Diagnostics researchers. Their review of more than ... with UPMC pathologists resulted in significantly altered treatment plans for more than half ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):